mm1313亚洲精品,欧美俄罗斯40老熟妇,欧美日韩在线观看视频在线,亚洲欧美国产激情综合在线

掃碼關(guān)注公眾號           掃碼咨詢技術(shù)支持           掃碼咨詢技術(shù)服務(wù)
  
客服熱線:400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  人才招聘  關(guān)于我們  聯(lián)系我們
中文字幕中文字幕久久,国产精品国产三级国产av视色,久久久精品日韩欧美
Rabbit Anti-PGRPS/Cy5 Conjugated antibody (bs-7673R-Cy5)
訂購熱線:400-901-9800
訂購郵箱:sales@www.p2b3.cn
訂購QQ:  400-901-9800
技術(shù)支持:techsupport@www.p2b3.cn
說 明 書: 100ul  
100ul/2980.00元
大包裝/詢價
產(chǎn)品編號 bs-7673R-Cy5
英文名稱1 Rabbit Anti-PGRPS/Cy5 Conjugated antibody
中文名稱 Cy5標(biāo)記的肽聚糖識別蛋白1抗體
別    名 Peptidoglycan recognition protein 1; Peptidoglycan recognition protein; PGLYRP; PGLYRP1; PGRP; PGRP S; PGRP-PEN; PGRP-S; TAG7; TNFSF 3L; TNFSF3L; PGRP1_HUMAN.  
規(guī)格價格 100ul/2980元 購買        大包裝/詢價
說 明 書 100ul  
研究領(lǐng)域 細(xì)胞生物  微生物學(xué)  神經(jīng)生物學(xué)  細(xì)胞凋亡  細(xì)菌及病毒  糖蛋白  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) (predicted: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, )
產(chǎn)品應(yīng)用 IF=1:50-200 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 19kDa
性    狀 Lyophilized or Liquid
濃    度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from human PGRPS
亞    型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
產(chǎn)品介紹 background:
The primary immune recognition is based on structures common among invading pathogens. Bacterial surface molecules, such as lipopolysaccharide (LPS) and peptidoglycan (PGN), are known to elicit immune reactions ranging from cytokine release to fever. Recently, a family of proteins called peptidoglycan recognition protein (PGRP) has been identified in mouse and human that binds to peptidoglycans expressed on Gram-positive bacteria. Peptidoglycan (PGN) is an essential cell wall component of virtually all bacteria and, thus, it is an excellent target for recognition by the eukaryotic innate immune system. The PGRPs (PGRP-L, PGRPS, PGRPIA, and PGRP-I-beta) define a new family of human pattern recognition molecules. PGRP-L is primarily expressed in the liver. Although liver is not considered a primary immune organ, liver participates in host defenses by producing acute phase proteins (by hepatocytes) in response to infections and by clearing microorganisms from blood. PGRPS is present in neutrophils and inhibits growth of Gram-positive bacteria and, therefore, may function as a neutrophil antibacterial protein. However, PGRPS may have another, as yet unidentified function because in humans it is expressed in the bone marrow 50–100 times higher than in neutrophils.

Function:
Pattern receptor that binds to murein peptidoglycans(PGN) of Gram-positive bacteria. Has bactericidal activity towardsGram-positive bacteria. May kill Gram-positive bacteria byinterfering with peptidoglycan biosynthesis. Binds also toGram-negative bacteria, and has bacteriostatic activity towardsGram-negative bacteria. Plays a role in innate immunity.

Subunit:
Homodimer; disulfide-linked.

Subcellular Location:
Secreted. Cytoplasmic granule (Bysimilarity).

Tissue Specificity:
Highly expressed in bone marrow. Weakexpression found in kidney, liver, small intestine, spleen, thymus,peripheral leukocyte, lung, fetal spleen and neutrophils.

Post-translational modifications:
N-glycosylated. N-glycosylation is required for bactericidalactivity.

Similarity:
Belongs to the N-acetylmuramoyl-L-alanine amidase 2family.

Database links:
UniProtKB/Swiss-Prot: O75594.1

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
版權(quán)所有 2004-2026 www.www.p2b3.cn 北京博奧森生物技術(shù)有限公司
通過國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網(wǎng)安備110107000727號
广安市| 青海省| 丰城市| 修水县| 永吉县| 宽甸| 嘉荫县| 泾川县| 上饶市| 辰溪县| 竹北市| 聂荣县| 临邑县| 巧家县| 崇礼县| 安溪县| 江永县| 祁门县| 济源市| 永川市| 延安市| 美姑县| 雷山县| 于田县| 苏尼特右旗| 桐乡市| 灵山县| 奉贤区| 全椒县| 曲麻莱县| 德阳市| 东安县| 蓬莱市| 西充县| 德钦县| 民权县| 鹤壁市| 公安县| 文成县| 纳雍县| 清涧县|